Clinical Data to Acquire Troubled Icoria for $12.5M, Will Pair Metabolomics with Genaissance Offerings | GenomeWeb

With the ink barely dry on its deal to acquire Genaissance, announced in June, Clinical Data said this week that it plans to acquire Icoria in an all-stock transaction valued at approximately $12.5 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.